This research on a T-cell–targeting vaccine in HIV has implications for future study design to incorporate consideration of ...

Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...

A human papillomavirus (HPV) vaccine will be manufactured there, according to Merck's website. "Expanding our state-of-the-art manufacturing facility in Durham marks a significant milestone in our ...

Merck & Co. (MSD outside the U.S. and Canada) has just unveiled a brand-new, cutting-edge vaccine manufacturing facility at its site in Durham, North Carolina. The $1 billion expansion is a big step ...